![PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper](https://i1.rgstatic.net/publication/329095838_Use_of_cyclin-dependent_kinase_46_CDK46_inhibitors_in_older_patients_with_ER-positive_HER2-negative_breast_cancer_Young_International_Society_of_Geriatric_Oncology_review_paper/links/5bf5745b4585150b2bc8ac62/largepreview.png)
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
![Gabor Liposits on Twitter: Gabor Liposits on Twitter:](https://pbs.twimg.com/media/DsMw16NWkAAw-8Y.jpg)
Gabor Liposits on Twitter: "Excellent presentation by @DrR_DUNNE on malnutrition at the Young SIOG poster walk. Great job by @MelissaLoh21 @rochgerionc Congratulations!! #YoungSIOG #SIOG2018… https://t.co/NA3go8hN8P"
![Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology](https://i1.rgstatic.net/ii/profile.image/899362599231489-1591436161724_Q512/Fabio_Gomes11.jpg)
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
![PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42206818/mini_magick20190218-13468-1tsktds.png?1550479188)
PDF) 3-D Conformal Photon Boost in the Treatment of Early Stage Breast Cancer: Four Year Follow Up Results | Ákos Horváth, Gabor Liposits, and Ferenc Lakosi - Academia.edu
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
![Gabor LIPOSITS | PhD Student | University of Southern Denmark, Odense | SDU | Institute of Clinical Research Gabor LIPOSITS | PhD Student | University of Southern Denmark, Odense | SDU | Institute of Clinical Research](https://i1.rgstatic.net/ii/profile.image/757241141542914-1557551765553_Q512/Gabor_Liposits.jpg)
Gabor LIPOSITS | PhD Student | University of Southern Denmark, Odense | SDU | Institute of Clinical Research
![Gabor Liposits в Twitter: Gabor Liposits в Twitter:](https://pbs.twimg.com/media/DwDQ0GJWkAAGDe9.jpg)
Gabor Liposits в Twitter: "ESMO's official decision support system the ONCOassist app included G8 screening tool. Important step forward getting more recognition for #gerionc. Get it today! It is free! @YoungSIOG @SIOGorg @
![PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials](https://i1.rgstatic.net/publication/344250532_Olaparib_treatment_in_older_patients_with_ovarian_cancer_need_for_'real-world'_data_beyond_clinical_trials/links/5f60aa2692851c0789679ea6/largepreview.png)